Treatment of liver metastases

被引:0
|
作者
Riediger, Carina [1 ]
Kuehn, Jens-Peter [2 ]
Krause, Mechthild [3 ]
Lohaus, Fabian [3 ]
Folprecht, Gunnar [1 ,4 ]
机构
[1] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Klin & Poliklin Viszeral Thorax & Gefasschirurg, Dresden, Germany
[2] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Inst & Poliklin Diagnost & Intervent Radiol, Dresden, Germany
[3] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Klin Poliklin Strahlentherapie & Radioonkol, Dresden, Germany
[4] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Med Klin & Poliklin 1, Hamatol Zelltherapie & Med Onkol, Dresden, Germany
来源
ONKOLOGIE | 2023年 / 29卷 / 03期
关键词
Colorectal liver metastases; Neuroendocrine liver metastases; Non-colorectal; non-neuroendocrine liver metastases; Hemihepatectomy; Comorbidity; PORTAL-VEIN EMBOLIZATION; FOLFIRI PLUS BEVACIZUMAB; COLORECTAL-CANCER FIRE-3; NEUROENDOCRINE TUMORS; OPEN-LABEL; 1ST-LINE TREATMENT; HEPATIC RESECTION; PATIENT SELECTION; CETUXIMAB; TRANSPLANTATION;
D O I
10.1007/s00761-023-01302-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The liver is the main destination for distant metastases of gastrointestinal as well as other malignancies. Consequently, the therapy of liver metastases plays a key role in oncological treatment strategies.Objectives In this review, the current treatment options and multimodal therapy strategies for liver metastases are presented.Materials and methods Current literature and national/international consensus guidelines are reviewed and general treatment options for liver metastases are summarized and then presented for the respective malignancies.Results According to treatment strategy and prognosis, liver metastases are divided into three categories: colorectal liver metastases (CRLM), neuroendocrine liver metastases, and non-colorectal non-neuroendocrine liver metastases which include liver metastases of all other malignancies. Due to their highest incidence, CRLM are of major interest. The individual treatment is chosen according to patient's oncological situation, liver function, and comorbidities.Conclusions Surgery is the best curative treatment option. Thus, all patients should be evaluated for surgery in specialized oncological boards. Despite higher local recurrence, local ablation methods are good alternative options for small and limited metastases. Systemic treatments and radiation are implemented in palliative settings as well as multimodal treatment strategies with the goal of cure.
引用
收藏
页码:192 / 201
页数:10
相关论文
共 50 条
  • [1] TREATMENT OF LIVER METASTASES
    GAYRAL, F
    PRESSE MEDICALE, 1990, 19 (24): : 1126 - 1127
  • [2] TREATMENT OF LIVER METASTASES
    GOEAUBRISSONNIERE, O
    PATEL, JC
    PRESSE MEDICALE, 1984, 13 (10): : 611 - 614
  • [3] Percutaneous treatment of liver metastases
    Trübenbach, J
    Schmidt, D
    Pereira, PL
    ZENTRALBLATT FUR CHIRURGIE, 2003, 128 (11): : 920 - 927
  • [4] Treatment of patients with liver metastases
    Fumoleau, P
    ANTI-CANCER DRUGS, 1996, 7 : 21 - 23
  • [5] Percutaneous treatment of liver metastases
    Joseph P Erinjeri
    Cancer Imaging, 15 (Suppl 1)
  • [6] Treatment of colorectal liver metastases
    Folprecht, G.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (41) : 2098 - 2103
  • [7] Treatment of colorectal liver metastases
    Geoghegan, JG
    Scheele, J
    BRITISH JOURNAL OF SURGERY, 1999, 86 (02) : 158 - 169
  • [8] Percutaneous treatment of liver metastases
    Adam, A
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2000, 63 (02): : 163 - 164
  • [9] Surgical treatment of liver metastases
    Loss, M.
    Jung, E. M.
    Scherer, M. N.
    Farkas, S. A.
    Schlitt, H. J.
    CHIRURG, 2010, 81 (06): : 533 - 541
  • [10] LIVER METASTASES - TREATMENT BY CRYOTHERAPY
    CHARNLEY, RM
    DORAN, J
    MORRIS, DL
    GUT, 1989, 30 (10) : A1497 - A1497